Variant report
Variant | nsv516342 |
---|---|
Chromosome Location | chr9:11155468-11159953 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PTPRD-3 | chr9:11159533-11159565 | XLOC_007645 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs571024822 | chr9:11158234-11158235 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
2 | rs533300598 | chr9:11158235-11158236 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
3 | rs144935575 | chr9:11158263-11158264 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
4 | rs1931422 | chr9:11158296-11158297 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
5 | rs79450042 | chr9:11158309-11158310 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
6 | rs1931423 | chr9:11158314-11158315 | Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs566235176 | chr9:11158318-11158319 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
8 | rs370630080 | chr9:11158325-11158326 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
9 | rs578220951 | chr9:11158326-11158327 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
10 | rs77238107 | chr9:11158332-11158333 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
11 | rs1931424 | chr9:11158345-11158346 | Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
12 | rs528655635 | chr9:11158386-11158387 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
13 | rs568614212 | chr9:11158418-11158419 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs551996193 | chr9:11158421-11158422 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs142043766 | chr9:11158427-11158428 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs537707016 | chr9:11158429-11158430 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs151227778 | chr9:11158461-11158462 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs567291811 | chr9:11158463-11158464 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs1931425 | chr9:11158480-11158481 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs553031175 | chr9:11158486-11158487 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs573050074 | chr9:11158493-11158494 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs141389423 | chr9:11158557-11158558 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs557894847 | chr9:11158577-11158578 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs535175548 | chr9:11158627-11158628 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs543673499 | chr9:11158641-11158642 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs188330096 | chr9:11158659-11158660 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs528878880 | chr9:11158663-11158664 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs180757999 | chr9:11158675-11158676 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs185598181 | chr9:11158689-11158690 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs528229742 | chr9:11158692-11158693 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs199994971 | chr9:11158706-11158707 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs549572550 | chr9:11158731-11158732 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs571764463 | chr9:11158779-11158780 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs559117829 | chr9:11158786-11158787 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs146986768 | chr9:11158796-11158797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs147626481 | chr9:11158835-11158836 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs528078090 | chr9:11158879-11158880 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs73641399 | chr9:11158900-11158901 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs1931426 | chr9:11158911-11158912 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs552992344 | chr9:11158912-11158913 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs566763493 | chr9:11158918-11158919 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs142168157 | chr9:11158975-11158976 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs539077336 | chr9:11159085-11159086 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs564790223 | chr9:11159087-11159088 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs189962298 | chr9:11159116-11159117 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs577732203 | chr9:11159134-11159135 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs183756945 | chr9:11159139-11159140 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs150437245 | chr9:11159143-11159144 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs576589158 | chr9:11159185-11159186 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs574030808 | chr9:11159190-11159191 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Cancer | 20164920 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21611746 | CNVD |
Melanoma | 22183965 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:11158200-11158400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr9:11158200-11158400 | Bivalent Enhancer | Foreskin Keratinocyte Primary Cells skin02 | Skin |
3 | chr9:11158400-11158800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
4 | chr9:11158800-11159200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
5 | chr9:11159200-11160000 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |